SciEmploy.ca » Quebec

CATO Research

Jeff — Fri, 05 Feb 2010 22:07:33 +0000

Our employees are extraordinarily talented, creative, and experienced, and they work passionately to help pharmaceutical and biotechnology companies bring products to market by designing and implementing nonclinical, regulatory, product development, manufacturing, and clinical strategies for drugs, biologics, and medical devices. The outcome may be a vaccine for multiple sclerosis, a more effective HIV diagnostic tool, or novel treatment for a rare disease. Additionally, we also understand your need to get your unique product into the marketplace quickly.

Bristol-Myers Squibb

Jeff — Fri, 05 Feb 2010 22:04:50 +0000

With nearly 80 years in Canada, Bristol-Myers Squibb Canada is positioned to be a leading contributor to Canada’s global reputation in the health and pharmaceutical business.

Canada has been indispensable in helping Bristol-Myers Squibb Canada live up to its pledge of fostering a globally diverse work force. Together our employees represent many cultures and backgrounds, but are bound together by the desire to extend and enhance human life.

BioMatera

Jeff — Wed, 03 Feb 2010 21:55:41 +0000

A company active in the field of environmental technologies, BioMatera has distinguished itself by developing an innovative process to produce a range of completely biodegradable polymers from renewable raw materials. These polymers are part of a broad family of natural compounds, the PHAs (PolyHydroxyAlkanoates). With properties equivalent to conventional plastic, PHAs offer an alternative to similar products derived mostly from petroleum.

Biophage Pharma

Jeff — Wed, 03 Feb 2010 21:55:40 +0000

Biophage Pharma Inc. is a Canadian biopharmaceutical company developing, via its fully own subsidiary Biophage Inc., new products in an integrated approach against bacterial infections: combining therapeutic and diagnostic products based on phage technology.

AstraZeneca

Jeff — Mon, 01 Feb 2010 17:10:48 +0000

AstraZeneca is one of the largest pharmaceutical companies in the world. As a research-oriented company, we believe that curiosity is the best way to express our commitment to the health of Canadians. Looking beyond the obvious and solving problems in innovative ways drives the researchers we support and our scientists toward the discovery of new and better treatments for medical conditions and diseases.

Axoneme Inc.

Jeff — Mon, 01 Feb 2010 17:09:58 +0000

Axoneme is a privately owned company specialised in Contract Research and Development for clients from Academic and Industrial field with need related to every aspects of Recombinant Proteins.

Axcan Pharma

Jeff — Mon, 11 Jan 2010 15:30:04 +0000

Axcan is a privately-held leading specialty pharmaceutical company focused on gastroenterology. We market a wide range of products to treat gastrointestinal diseases and disorders, such as Inflammatory Bowel Disease, cholestatic liver diseases, Irritable Bowel Syndrome and pancreatic enzyme insufficiency.

Within the framework of its commitment to gastroenterology, Axcan is driven by its dedication to constantly innovate to provide improved therapies and meet patients’ needs.

Aurelium BioPharma

Jeff — Mon, 11 Jan 2010 15:27:39 +0000

Aurelium BioPharma Inc., a privately held company, focuses on developing novel diagnostic products in oncology.

The company has developed several diagnostic tests for the detection of breast, ovarian as well as drug-resistant cancers. Aurelium has a strong “drugable” pipeline of novel targets and complimentary diagnostic products that are utilized in its strategic collaborations and out-licensing efforts.

Atrium Innovations

Jeff — Mon, 11 Jan 2010 15:25:15 +0000

We are proud to be leading the premium natural health supplement industry by bringing together forward-looking brands that are best in class in their own right. Brands recognized for their product innovation, their manufacturing excellence, their business savvy. Brands that offer superior-quality products and services backed by scientific research and recognized by reputable healthcare professionals.

ArthroLab

Jeff — Sun, 10 Jan 2010 07:28:47 +0000

ArthroLab Inc., headquartered in Montreal, Quebec, Canada, was incorporated in May 1994 by Doctors Jean-Pierre Pelletier and Johanne Martel-Pelletier. The company’s initial objective was to perform preclinical (in vitro and in vivo in animals) and clinical trials on a contractual basis for pharmaceutical companies engaged in the development of new agents for the treatment of osteoarthritis.